Aruna Bio Revenue and Competitors
Estimated Revenue & Valuation
- Aruna Bio's estimated annual revenue is currently $2.9M per year.
- Aruna Bio's estimated revenue per employee is $65,461
- Aruna Bio's total funding is $34.8M.
Employee Data
- Aruna Bio has 45 Employees.
- Aruna Bio grew their employee count by 7% last year.
Aruna Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.1M | 18 | -18% | N/A | N/A |
#2 | $3.5M | 43 | 13% | N/A | N/A |
#3 | $3.2M | 39 | 0% | N/A | N/A |
#4 | $3.5M | 43 | N/A | N/A | N/A |
#5 | $3.6M | 44 | 5% | N/A | N/A |
#6 | $2M | 28 | 8% | N/A | N/A |
#7 | $22.8M | 203 | 2% | N/A | N/A |
#8 | $0.2M | 4 | N/A | N/A | N/A |
#9 | $3.1M | 38 | 9% | N/A | N/A |
#10 | $1M | 17 | -11% | N/A | N/A |
What Is Aruna Bio?
Aruna Bio was the first to commercialize human neural stem cells derived from human pluripotent stem cells. For over twelve years, we manufactured and provided neural stem cells to the world’s leading research organizations with unrivaled uniformity and scale. Today, we are advancing a new class of cell-free biologics, exosomes, for the treatment of neurodegenerative disorders and leveraging our novel platform to optimize the delivery of RNAs, antibodies, genes and small molecules for our partners.
keywords:N/A
$34.8M
Total Funding
45
Number of Employees
$2.9M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aruna Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, Nonclinical Research | Reveal Email/Phone |
2 | Director Quality | Reveal Email/Phone |
3 | Research Scientist, Discovery | Reveal Email/Phone |
4 | Research Associate | Reveal Email/Phone |
5 | Research associate II | Reveal Email/Phone |
6 | Analytical Development Scientist | Reveal Email/Phone |
Aruna Bio News
In January 2019, Dr. Sirgo was appointed Chief Executive Officer of Aruna Bio, Inc., a private development-stage company focused on central...
ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the closing of a common stock financing totaling $10.8 million. Proceeds from the rais ...
ArunA Bio, a biotech company based in Athens, has raised $13 million from Eshelman Ventures, members of the company’s board of directors and management, and other investors. ArunA Bio will use the funding to support the development of its neural exosome delivery platform and neural exosome ther ...
ArunA Bio, Inc., an Athens, Ga.-based leader in the development of neural exosomes for the treatment of neurodegenerative diseases, completed a $13m common stock financing. The financing included both existing and new private investors along with participation by several institutional investors ...
Other Companies in Athens-Clarke
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 69 | -1% | N/A |
#2 | $26.7M | 81 | 5% | N/A |
#3 | $23M | 85 | -13% | N/A |
#4 | $20.2M | 96 | 1% | N/A |
#5 | $29.3M | 101 | 5% | N/A |